PositiveID Corporation (fka PSID)

[hakus]

Some thing for new and old may be

Leidos signs a pharma deal with US Defense Department
Posted on 25 April 2014
Tags: biotech, contract, pharma alliances, pharma deals
Leidos was awarded a pharma deal with prime contract by the U.S. Defense Threat Reduction Agency to conduct research and development to combat weapons of mass destruction.
The multiple-award indefinite delivery/indefinite quantity contract has a five-year base period of performance, a five year option, and a total value of approximately $4 billion for all awardees, if all options are exercised.
The contract was awarded under the Combating Weapons of Mass Destruction Research and Technology Development ID/IQ contract.
In October 2012, PositiveID entered into a Teaming Agreement with Leidos, which paired Leidos’ system engineering and integration capabilities with PositiveID’s bio-threat detection technologies.
PositiveID will offer both its Firefly Dx handheld diagnostic system (“Firefly”) as well as its M-BAND (Microfluidics-based Bioagent Networked Detector) airborne bio-threat detector as part of the Teaming Agreement.